ArticleToxins2022

Improved Therapy of B-Cell Non-Hodgkin Lymphoma by Obinutuzumab-Dianthin Conjugates in Combination with the Endosomal Escape Enhancer SO1861.

Hossein Panjideh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.